XtalPi Holdings Limited (QNTPF)

Market Cap	2.56B
Revenue (ttm)	36.50M
Net Income (ttm)	-207.78M
Shares Out	n/a
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	8
Open	1.000
Previous Close	1.000
Day's Range	1.000 - 1.000
52-Week Range	1.000 - 1.000
Beta	n/a
RSI	n/a
Earnings Date	May 28, 2025

About XtalPi Holdings

XtalPi Holdings Limited, an investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally. The company offers XMolGen, an AI small molecule drug discovery smart computation platform; XtalFold, an antibody-antigen complex structure prediction platform which predicts the antibody-antigen complex structure and identifies key interaction sites; and Xtalgazer, a new generation of drug crystallization research and development platform which predict the physicoch...

• Industry: Commercial Physical and Biological Research
• Founded: 2015
• Employees: 809
• Stock Exchange: OTCMKTS
• Ticker Symbol: QNTPF

Financial Performance

In 2024, XtalPi Holdings's revenue was 266.43 million, an increase of 52.75% compared to the previous year's 174.42 million. Losses were -1.52 billion, -20.78% less than in 2023.

Financial numbers in CNY